Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
san francisco
san francisco blog main
san francisco top stories
3
×
boston blog main
boston top stories
fda
national top stories
raleigh-durham blog main
seattle blog main
seattle top stories
aimmune therapeutics
allergy
anaphylaxis
andrew oxtoby
biobucks
boulder/denver blog main
boulder/denver top stories
calistoga pharmaceuticals
car-t immunotherapy
checkpoint inhibitors
clinical trials
daniel edelman
deals
detroit blog main
detroit top stories
eosinophilic esophagitis
food allergy
food and drug administration
gilead sciences
idelalisib
immuno-oncology
immunotherapy
indiana blog main
indiana top stories
jayson dallas
kite pharma
kymriah
What
drug
3
×
therapeutics
3
×
therapy
adding
agency
aimmune
allergy
approval
approved
awarded
bets
boost
building
cancer
deal
developed
developer
disease
established
expensive
far
fda
firm
friday
gilead
immunotherapy
late
lung
million
momentum
oral
pah
paying
peanut
pipeline
program
rare
reaches
rivalry
sciences
Language
unset
Current search:
therapeutics
×
drug
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed